Prosecution Insights
Last updated: April 19, 2026

Mammoth Biosciences Inc.

7 pending office actions

Portfolio Summary

7
Total Pending OAs
1
Final Rejections
6
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18469512 EFFECTOR PROTEINS, EFFECTOR PARTNERS, COMPOSITIONS, SYSTEMS AND METHODS OF USE THEREOF HIBBERT, CATHERINE S 1658 Non-Final OA Sep 18, 2023
18334327 METHODS AND COMPOSITIONS FOR PERFORMING A DETECTION ASSAY VANN-OJUEKAIYE, KENDRA RAYCHELL 1682 Non-Final OA Jun 13, 2023
18000640 PROGRAMMABLE NUCLEASES AND METHODS OF USE RAVINDRA, KRISHNA NUGGEHALLI 1636 Non-Final OA Dec 02, 2022
18058122 PROGRAMMABLE NUCLEASE DIAGNOSTIC DEVICE GERHARD, ALISON CLAIRE 1797 Non-Final OA Nov 22, 2022
17935042 EFFECTOR PROTEINS AND METHODS OF USE LIPPOLIS, ALEXANDRA ROSE 1637 Non-Final OA Sep 23, 2022
17629895 COMPOSITIONS FOR DETECTION OF DNA AND METHODS OF USE THEREOF SCHLOOP, ALLISON ELIZABETH 1683 Non-Final OA Jan 25, 2022
17555236 ASSAYS AND METHODS FOR DETECTION OF NUCLEIC ACIDS WHITE, DENNIS MICHAEL 1758 Final Rejection Dec 17, 2021

Managing Mammoth Biosciences Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month